Sweroside inhibits the ROS-mediated NF-κB/NLRP3 inflammasome pathway in cardiomyocytes by directly binding to CaMKIIδ, alleviating myocardial inflammation and adverse cardiac remodeling, thereby improving HF induced by pressure overload (156). The gene discussed is NLRP3; the disease is hydrops fetalis.